George Sellers
Stock Analyst at Stephens & Co.
(1.30)
# 3,636
Out of 5,015 analysts
43
Total ratings
27.27%
Success rate
-7.09%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $38.94 | +74.63% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $119.42 | +142.84% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $31.85 | +82.10% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $107.29 | +65.91% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $9.02 | +166.08% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $29.69 | +142.51% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $2.97 | +68.35% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $5.88 | +325.17% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $26.68 | +113.64% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $82.56 | -14.00% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $38.94
Upside: +74.63%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $119.42
Upside: +142.84%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $31.85
Upside: +82.10%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $107.29
Upside: +65.91%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.02
Upside: +166.08%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $29.69
Upside: +142.51%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $2.97
Upside: +68.35%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $5.88
Upside: +325.17%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $26.68
Upside: +113.64%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $82.56
Upside: -14.00%